Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by GoBlue2016on Aug 18, 2019 6:27pm
200 Views
Post# 30041291

RE:RE:RE:Analysis of Aphria. The Turnaround Is Missing Some Key Piece

RE:RE:RE:Analysis of Aphria. The Turnaround Is Missing Some Key Piece$120 million error. No biggie

They should put their crayons back in the box.  

Their conclusion...

 

“In summary, we think Aphria is unlikely to achieve its stated fiscal 2020 guidance unless the company achieves significantly lower all-in production costs and make deep cuts in its SG&A expenses.”

 

I just carved $120 million out of “their SGA”... 


GoBlue
Bullboard Posts